Differences between living and deceased donation in human uterus transplantation: A narrative review

Review OA: gold CC-BY-NC-4.0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-15 ⓘ

This narrative review compares living and deceased donor uterus transplantation, finding that while deceased donation poses lower donor risks, it yields higher live birth rates despite greater graft failure, suggesting both sources remain necessary.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-25 · read from full text ⓘ

This narrative review compares living donor (LD) and deceased donor (DD) uterus transplantation, analyzing risks, surgical complexities, and psychological outcomes for both donors and recipients. The authors highlight that LD procedures carry significant surgical and long-term health risks, including complications from hysterectomy and potential early menopause, while DD grafts present challenges in vascular assessment and hemorrhage control during reperfusion. Additionally, the paper discusses distinct psychosocial burdens, such as body image distortion in LDs and complex interpersonal dynamics or guilt in recipients receiving organs from known donors. Relevance to endometriosis: severe adenomyosis is explicitly listed as one of the pathologies causing absolute uterine factor infertility that may be treated with uterus transplantation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The decision to use a living or deceased donor to perform uterus transplantation (UTx) is an evaluation of benefit and harm and is based on the medical team's choices. The current study determines the differences between living and deceased donation in human UTx according to determinant factors in choosing the donor type. For this review study, the PubMed database was searched without time, language, and location limitations up to May 2022. From 113 identified articles, 45 papers were included in the study for review. According to the results, in comparison to living donation, the biggest advantage of deceased donation is the lack of surgical and or psychological risks for the donor. In contrast, a comprehensive pre-transplantation medical assessment is less possible in deceased donation, and preplanned surgery cannot be realized. According to published peer-reviewed clinical trials on UTx, the graft failure rates in living and deceased donor UTx are 21% and 36%, respectively. Supposing all recipients who did not have graft failure underwent embryo transfer, live birth rates in living and deceased donor UTx procedures are almost 63% and 71%, respectively. Currently, considering the occurrence of live births from both donations, particularly from nulliparous deceased donor, increased demand for UTx in the near future, shortage of uterus grafts, and lack of sufficient data for a comprehensive comparison between the 2 types of donation, the use of both donations still seems necessary and rational.
Full text 26,738 characters · extracted from pmc-nxml · 2 sections · click to expand

Section

Both living and deceased donations can provide suitable uteri for delivering a healthy neonate. The main disadvantage of using LD is the risks for the donor. In the deceased donation, there is no such concern; however, restricted uterus assessment before donation and the lack of the possibility for planned surgery are the main disadvantages of using the uterus of DD. Given the insufficient available data, it is difficult to compare the clinical outcomes between the 2 types of donation. Therefore, it is rational to use a combination of both LD and DD at this stage.

Coi Statement

The author declares that she has no conflict of interest in the present study.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
pubmed
last seen: 2026-10-08T21:39:34.049699+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-4.0